Anthem (NYSE: ANTM) reported Q3 EPS of $3.81, $0.11 better than the analyst estimate of $3.70. Revenue for the quarter came in at $22.98 billion versus the consensus estimate of $22.93 billion.

• Third quarter net income was $960 million, growth of 29% over the prior year quarter. Adjusted net income of $3.81 per share grew by 44% year over year.
• Medical enrollment increased by 5 thousand members sequentially, totaling approximately 39.5 million members as of September 30, 2018.
• Benefit Expense Ratio was 84.8% driven by solid medical cost performance.
• Full year 2018 GAAP net income is now expected to be greater than $14.46 per share. Full year 2018 adjusted net income is now expected to be greater than $15.60 per share.
• Fourth quarter 2018 dividend of $0.75 per share declared to shareholders.

"Our third quarter 2018 results reflect solid operating performance and ongoing positive momentum across our businesses, and I am confident that we are entering 2019 in a position of strength. We have made significant progress towards improving execution and are focused on advancing our consumer, clinical, and digital capabilities. We remain committed to accelerating growth and will continue to invest in innovative, effective, and scalable healthcare solutions designed to improve the quality and total cost of care for our members," said Gail K. Boudreaux, President and CEO. "I am pleased with our results through the first nine months of 2018. As result, we have increased our 2018 outlook to reflect our expectation for continued growth."

GUIDANCE:

Anthem sees Q4 2018 EPS of $15.60, versus the consensus of $15.50. Anthem sees Q4 2018 revenue of $91-92 billion, versus the consensus of $91.43 billion.

For earnings history and earnings-related data on Anthem (ANTM) click here.